Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

139 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Trastuzumab deruxtecan in patients with central nervous system involvement from HER2-positive breast cancer: The DEBBRAH trial.
Pérez-García JM, Vaz Batista M, Cortez P, Ruiz-Borrego M, Cejalvo JM, de la Haba-Rodriguez J, Garrigós L, Racca F, Servitja S, Blanch S, Gion M, Nave M, Fernández-Abad M, Martinez-Bueno A, Llombart-Cussac A, Sampayo-Cordero M, Malfettone A, Cortés J, Braga S. Pérez-García JM, et al. Among authors: cortez p. Neuro Oncol. 2023 Jan 5;25(1):157-166. doi: 10.1093/neuonc/noac144. Neuro Oncol. 2023. PMID: 35639825 Free PMC article. Clinical Trial.
Can we cure oligometastatic disease? A practical point of view.
Pérez-García J, Cortez P, Gion M, Cortés J. Pérez-García J, et al. Among authors: cortez p. Curr Opin Oncol. 2020 Nov;32(6):568-574. doi: 10.1097/CCO.0000000000000684. Curr Opin Oncol. 2020. PMID: 32925203 Review.
Exploring the Combined Action of Adding Pertuzumab to Branded Trastuzumab versus Trastuzumab Biosimilars for Treating HER2+ Breast Cancer.
Franco-Mateos E, Souza-Egipsy V, García-Estévez L, Pérez-García J, Gion M, Garrigós L, Cortez P, Saavedra C, Gómez P, Ortiz C, Cruz VL, Ramos J, Cortés J, Vega JF. Franco-Mateos E, et al. Among authors: cortez p. Int J Mol Sci. 2024 Apr 1;25(7):3940. doi: 10.3390/ijms25073940. Int J Mol Sci. 2024. PMID: 38612751 Free PMC article.
Trastuzumab deruxtecan in patients with previously treated HER2-low advanced breast cancer and active brain metastases: the DEBBRAH trial.
Vaz Batista M, Pérez-García JM, Cortez P, Garrigós L, Fernández-Abad M, Gion M, Martínez-Bueno A, Saavedra C, Teruel I, Fernandez-Ortega A, Servitja S, Ruiz-Borrego M, de la Haba-Rodríguez J, Martrat G, Pérez-Escuredo J, Alcalá-López D, Sampayo-Cordero M, Braga S, Cortés J, Llombart-Cussac A. Vaz Batista M, et al. Among authors: cortez p. ESMO Open. 2024 Sep;9(9):103699. doi: 10.1016/j.esmoop.2024.103699. Epub 2024 Sep 9. ESMO Open. 2024. PMID: 39255534 Free PMC article. Clinical Trial.
The DEBBRAH trial: Trastuzumab deruxtecan in HER2-positive and HER2-low breast cancer patients with leptomeningeal carcinomatosis.
Vaz Batista M, Pérez-García JM, Garrigós L, García-Sáenz JÁ, Cortez P, Racca F, Blanch S, Ruiz-Borrego M, Fernández-Ortega A, Fernández-Abad M, Iranzo V, Gion M, Martrat G, Alcalá-López D, Pérez-Escuredo J, Sampayo-Cordero M, Llombart-Cussac A, Braga S, Cortés J. Vaz Batista M, et al. Among authors: cortez p. Med. 2025 Jan 10;6(1):100502. doi: 10.1016/j.medj.2024.08.001. Epub 2024 Sep 11. Med. 2025. PMID: 39265579 Clinical Trial.
Talus Osteonecrosis after Chemotherapy: A Case Report.
Barros LM, Cortez PPR, Souza EV, Mendes EC. Barros LM, et al. Among authors: cortez ppr. Rev Bras Ortop (Sao Paulo). 2024 Apr 22;59(Suppl 2):e224-e227. doi: 10.1055/s-0043-1771004. eCollection 2024 Nov. Rev Bras Ortop (Sao Paulo). 2024. PMID: 39735450 Free PMC article.
Environmental conditions affect the nutritive value and alkaloid profiles of Lupinus forage: Opportunities and threats for sustainable ruminant systems.
Cabrita ARJ, Valente IM, Monteiro A, Sousa C, Miranda C, Almeida A, Cortez PP, Castro C, Maia MRG, Trindade H, Fonseca AJM. Cabrita ARJ, et al. Among authors: cortez pp. Heliyon. 2024 Mar 27;10(7):e28790. doi: 10.1016/j.heliyon.2024.e28790. eCollection 2024 Apr 15. Heliyon. 2024. PMID: 38596022 Free PMC article.
139 results